Michał Kos

Michał Kos

Auto-generated profile, based on publicly available information

Michał Kos

II Chair and Department of Gynecology Medical University of Lublin Lublin 20-954 Poland umlub.pl

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2018 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
Michał KiełbusMichał Kiełbus
Michał Kiełbus
JCJakub Czapiński
Jakub Czapiński
AOAdrian Odrzywolski
Adrian Odrzywolski
GSGrażyna Stasiak
Grażyna Stasiak
KSKamila Szymańska
Kamila Szymańska
Adolfo Rivero-MüllerAdolfo Rivero-Müller
Adolfo Rivero-Müller
The discovery and domestication of biomolecules that respond to light has taken a light of its own, providing new molecular tools with incredible spatio-temporal resolution to manipulate cellular behavior. Areas covered: The authors herein analyze the current optogenetic tools in light of their current, and potential, uses in cancer drug discovery, biosafety and cancer biology. Expert opinion: The pipeline from drug discovery to the clinic is plagued with drawbacks, where most drugs fail in either efficacy or safety. These issues require the redesign of the pipeline and the development of more controllable/personalized therapies. Light is, aside from inexpensive, almost harmless if used appropriately, can be directed to single cells or organs with controllable penetration, and comes in a variety of wavelengths. Light-responsive systems can activate, inhibit or compensate cell signaling pathways or specific cellular events, allowing the specific control of the genome and epigenome, and modulate cell fate and transformation. These synthetic molecular tools have the potential to revolutionize drug discovery and cancer research.

28 February 2021 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Open access
PDF file
JDJustyna Drankowska
Justyna Drankowska
MKMichał Kos
Michał Kos
JJJacek Jaworski
Jacek Jaworski
VPVéronique Petit
Véronique Petit
KWKatarzyna Wojtal
Katarzyna Wojtal
Konrad RejdakKonrad Rejdak
Konrad Rejdak
Aim of study. To examine whether baseline characteristics, potential risk factors, clinical symptoms, radiological presentation, and long-term outcomes differ between internal carotid artery dissection (ICAD) and vertebral artery dissection (VAD). Clinical rationale for study. Cervical artery dissection (CeAD) is a major cause of cerebral ischaemia in young adults. Its clinical course is highly variable, resulting in challenges in making a proper diagnosis. Methods. We performed a retrospective analysis of 31 patients (mean age 42.2 years) with CeAD (18 with ICAD, 13 with VAD) treated in our neurology department from 2008 to 2018. Appropriate imaging confirmed the diagnosis of CeAD. Results. Patients with ICAD presented Horner syndrome significantly more often (44.4% vs 7.6%; p = 0.04). Patients with VAD more often had ischaemic events (ischaemic stroke, TIA or transient blindness) (84.6% vs 44.6%; p = 0.0032). Ischaemic stroke was more severe in patients with ICAD [(median NIHSS 6, interquartile range 4–12) vs VAD (median NIHSS 4, interquartile range 1.5–5.5), p = 0,03]. Occlusion occurred more often in patients with VAD (69.2% vs 22.2%; p = 0.013). Most patients had a favourable outcome (mRS 0–2). Conclusions and clinical implications. In a series of patients with CeAD, we observed significant differences between VAD and ICAD in terms of clinical symptoms and radiological features. Aim of study. To examine whether baseline characteristics, potential risk factors, clinical symptoms, radiological presentation, and long-term outcomes differ between internal carotid artery dissection (ICAD) and vertebral artery dissection (VAD). Clinical rationale for study. Cervical artery dissection (CeAD) is a major cause of cerebral ischaemia in young adults. Its clinical course is highly variable, resulting in challenges in making a proper diagnosis. Methods. We performed a retrospective analysis of 31 patients (mean age 42.2 years) with CeAD (18 with ICAD, 13 with VAD) treated in our neurology department from 2008 to 2018. Appropriate imaging confirmed the diagnosis of CeAD. Results. Patients with ICAD presented Horner syndrome significantly more often (44.4% vs 7.6%; p = 0.04). Patients with VAD more often had ischaemic events (ischaemic stroke, TIA or transient blindness) (84.6% vs 44.6%; p = 0.0032). Ischaemic stroke was more severe in patients with ICAD [(median NIHSS 6, interquartile range 4–12) vs VAD (median NIHSS 4, interquartile range 1.5–5.5), p = 0,03]. Occlusion occurred more often in patients with VAD (69.2% vs 22.2%; p = 0.013). Most patients had a favourable outcome (mRS 0–2). Conclusions and clinical implications. In a series of patients with CeAD, we observed significant differences between VAD and ICAD in terms of clinical symptoms and radiological features.

1 January 2026 in International Journal of Inflammation
Verified
Journal Article
Open access
PDF file
MKMonika Kopeć
Monika Kopeć
MWMałgorzata Wojtaś
Małgorzata Wojtaś
AKAleksandra Kamińska
Aleksandra Kamińska
MKMichał Kos
Michał Kos
JKJan Kotarski
Jan Kotarski
MGMarek Zbigniew Gogacz
Marek Zbigniew Gogacz
It is supposed that the primary or secondary dysfunction of macrophages may play an essential role in the pathogenesis of endometriosis. It is postulated that macrophage‐derived cytokines and signaling molecules, such as IL‐1 (interleukin), IL‐6, and IL‐12, tumor necrosis factor‐alpha (TNF‐α), interferon‐gamma (IFN‐γ), and MCP‐1 (monocyte chemoattractant protein) may be involved in the process of endometriosis formation. This pilot study included 47 patients who underwent diagnostic–therapeutic laparoscopy at the II Department of Gynecology, Medical University of Lublin, Poland. Peritoneal fluid was obtained from patients in both the reference and study groups. The number and viability of the cells were assessed. The cells were labeled with monoclonal antibodies and assessed using flow cytometry. Interleukins of macrophage origin in the peritoneal fluid were determined using the enzyme‐linked immunosorbent assay (ELISA) test. The peritoneal fluid showed fundamental changes in the concentration of the studied cytokines. We recorded the peritoneal fluid volume for each patient (median ∼5 mL in the endometriosis group vs. ∼4 mL in the reference group) and noted that a larger volume could dilute cytokine levels; cytokine concentrations were thus interpreted per mL of fluid. More than twice as high median IL‐12 levels were detected in women in the reference group than in the study group. High levels of IL‐1α and low levels of IL‐12 in the study group compared to the reference group suggest an immunological component in the etiopathogenesis of endometriosis, although this pilot, exploratory study ( n = 47) cannot establish this relationship definitively. All endometriosis cases were laparoscopically confirmed, but histopathological confirmation was obtained in only 20 of 28 cases (71.4%); the remaining 8 patients had superficial Stage I lesions that were not biopsied. This study aimed to assess the concentrations of IL‐1α and IL‐12 in the PF of women with endometriosis compared to those with idiopathic infertility.